Four cases of definitive chemoradiotherapy with docetaxel/cisplatin/fluorouracil for advanced cervical esophageal cancer

被引:0
|
作者
Watanabe, Akinori [1 ]
Katada, Chikatoshi [1 ]
Furue, Yasuaki [1 ]
Wada, Takuya [1 ]
Ishido, Kenji [1 ]
Tanabe, Satoshi [1 ]
Koizumi, Wasaburo [1 ]
机构
[1] Kitasato Univ, Dept Gastroenterol, Sch Med, Tokyo, Japan
关键词
D O I
10.1016/j.annonc.2021.05.669
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1-11
引用
收藏
页码:S329 / S329
页数:1
相关论文
共 50 条
  • [1] Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer
    Okamoto, Hiroshi
    Taniyama, Yusuke
    Sakurai, Tadashi
    Heishi, Takahiro
    Teshima, Jin
    Sato, Chiaki
    Maruyama, Shota
    Ito, Ken
    Onodera, Yu
    Konno-Kumagai, Takuro
    Ishida, Hirotaka
    Kamei, Takashi
    [J]. ESOPHAGUS, 2018, 15 (04) : 281 - 285
  • [2] Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer
    Hiroshi Okamoto
    Yusuke Taniyama
    Tadashi Sakurai
    Takahiro Heishi
    Jin Teshima
    Chiaki Sato
    Shota Maruyama
    Ken Ito
    Yu Onodera
    Takuro Konno-Kumagai
    Hirotaka Ishida
    Takashi Kamei
    [J]. Esophagus, 2018, 15 : 281 - 285
  • [3] Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
    Hashimoto, Masashi
    Shirakawa, Yasuhiro
    Maeda, Naoaki
    Tanabe, Shunsuke
    Noma, Kazuhiro
    Sakurama, Kazufumi
    Katsui, Kuniaki
    Nishizaki, Masahiko
    Fujiwara, Toshiyoshi
    [J]. ESOPHAGUS, 2020, 17 (02) : 127 - 134
  • [4] Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
    Masashi Hashimoto
    Yasuhiro Shirakawa
    Naoaki Maeda
    Shunsuke Tanabe
    Kazuhiro Noma
    Kazufumi Sakurama
    Kuniaki Katsui
    Masahiko Nishizaki
    Toshiyoshi Fujiwara
    [J]. Esophagus, 2020, 17 : 127 - 134
  • [5] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Emi, Manabu
    Hihara, Jun
    Hamai, Yoichi
    Aoki, Yoshiro
    Okada, Morihito
    Kenjo, Masahiro
    Murakami, Yuji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1499 - 1505
  • [6] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Manabu Emi
    Jun Hihara
    Yoichi Hamai
    Yoshiro Aoki
    Morihito Okada
    Masahiro Kenjo
    Yuji Murakami
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 1499 - 1505
  • [7] Concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced esophageal cancer
    Cho, S.
    Sim, H.
    Hwang, J.
    Bae, W.
    Song, S.
    Nam, T.
    Na, K.
    Chung, I.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 379 - 379
  • [8] Definitive Chemoradiotherapy and Salvage Surgery for Advanced Cervical Esophageal Cancer
    Nakamura, Tsutomu
    Ota, Masaho
    Narumiya, Kosuke
    Sato, Takuya
    Ohki, Takeshi
    Yamamoto, Masakazu
    Mitsuhashi, Norio
    [J]. PROCEEDINGS OF THE 11TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR DISEASES OF THE ESOPHAGUS, 2008, : 221 - +
  • [9] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
    Tamaki, Yukihisa
    Hieda, Yoko
    Nakajima, Masanobu
    Kitajima, Kazuhiro
    Yoshida, Rika
    Yoshizako, Takeshi
    Ue, Atsushi
    Tokudo, Mutsumi
    Hirahara, Noriyuki
    Moriyama, Ichiro
    Kato, Hiroyuki
    Inomata, Taisuke
    [J]. JOURNAL OF CANCER, 2018, 9 (16): : 2765 - 2772
  • [10] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 449 - 455